Spirometer Market Size, Share & Industry Analysis, By Product Type (Devices, Software, and Accessories & Consumables), By Type (Volume Measurement and Peak Flow Meters), By Application (Chronic Obstructive Pulmonary Disorder (COPD), Asthma, and Others), By End User (Hospitals, Diagnostic Centers, Homecare Settings, Physician/Primary Care Offices or Clinics, and Other Facilities), and Regional Forecast, 2026-2034

The global spirometer market size was valued at USD 815.6 million in 2025. The market is projected to grow from USD 892.9 million in 2026 to USD 1,675.2 million by 2034, exhibiting a CAGR of 8.2% during the forecast period. North America dominated the spirometers market with a market share of 43.91% in 2025.

A spirometer is a diagnostic device used for measuring the air volume inspired and expired by the lungs. It is used to diagnose asthma, chronic obstructive pulmonary disease (COPD), and other conditions that affect breathing. The growing prevalence of respiratory disorders, increasing adoption of spirometry in clinical trials and drug development, among others, are some of the factors contributing to market growth.

• For instance, according to 2023 statistics published by the World Health Organization (WHO), it was reported that an estimated 363 million people were affected by asthma globally.

The growing introduction of technologically advanced products by major companies, including Jaeger Medical GmbH and Vitalograph, is contributing to the demand for these devices globally.

Download Free sample to learn more about this report.

Spirometer Market Trends

Shift toward Remote and Home-Based Spirometry for Chronic Respiratory Monitoring is a Key Market Trend

Respiratory care is shifting from episodic clinic-based testing toward decentralized and continuous monitoring. The growing prevalence of asthma, cystic fibrosis, COPD, lung transplant follow-up, neuromuscular respiratory weakness, and post-infectious respiratory complications is driving the demand for more frequent lung-function assessment outside conventional care facilities.

Home-based spirometers enable patients to measure lung-function parameters, including FEV₁, FVC, FEV₁/FVC ratio, PEF, and flow-volume patterns from home using portable or app-connected devices. These data can be transmitted to healthcare professionals through Bluetooth, mobile applications, remote patient monitoring platforms, cloud dashboards, or clinical-trial portals. This enables care teams to track disease trends, identify early deterioration, monitor treatment response, and intervene before severe exacerbations occur.

• For instance, in January 2024, NuvoAir Medical received formal 510(k) clearance for the innovative Air Next Spirometer for in-home use as a full spirometer. This approval empowers the company to scale and expand clinical operations to cater to growing numbers of patients with heart or lung conditions.

Market Dynamics

Market Drivers

Download Free sample to learn more about this report.

Increasing Adoption of Portable, Handheld, Connected, and Home-Use Spirometers to Boost Market Growth

Increasing investments by key market players in extensive R&D activities to develop advanced diagnostic and monitoring technologies, and further supporting the early diagnosis of COPD. Thus, technological innovations are expected to have a huge impact on the spirometer market growth. The integration of technological advancements, including portable, wireless, app-connected, cloud-enabled, calibration-free, and AI-assisted spirometry systems, is enhancing test quality, reducing operator dependency, enabling remote monitoring, and improving spirometry accessibility in primary care, home care, occupational health, pharmacies, clinical trials, and decentralized respiratory programs, further fueling the adoption rate of these devices globally.

• For instance, in May 2026, Medical International Research S.p.A. partnered with Locus Health, a company dedicated to integrated remote patient monitoring (RPM) solutions, to integrate the spirometry technology into the Locus Health RPM platform. This collaboration brings enhanced respiratory monitoring capabilities to the Locus Health platform, supporting clinical teams in delivering timely, data-driven care among the patient population.

Market Restraints                              

High Cost Associated with Advanced Systems to Hamper Market Growth

The high cost associated with advanced respiratory function testing devices and software integration is hampering the adoption of spirometers. The advanced devices used for complete respiratory function testing are significantly more expensive, as these include spirometry, lung-volume measurement, respiratory mechanics, DLCO testing, body plethysmography, advanced reporting software, EMR/EHR connectivity, calibration tools, accessories, and service contracts.

• For instance, according to the data published by CardiacDirect, it was reported that the cost of the MIR Spirolab Spirometer ranges from USD 3,100 to USD 3,500.

Market Opportunities

Expansion of Healthcare Infrastructure in Developing Nations to Create Growth Opportunities

Expansion of healthcare infrastructure across emerging nations represents a significant opportunity for the global market. Many low- and middle-income countries still face substantial under-penetration in spirometry devices, despite a growing prevalence of chronic respiratory disease among the patient population. There is an increasing demand for novel spirometer devices, EMR integration, disposable mouthpieces, bacterial/viral filters, calibration tools, staff training, and other recurring consumables, as governmental organizations and private healthcare providers are expanding telehealth networks, hospitals, primary care centers, and diagnostic laboratories. Overall, healthcare infrastructure and improved access are creating a major growth opportunity for spirometer manufacturers by increasing the number of care sites capable of performing lung-function testing.

• For instance, according to 2025 data published by the Government of India, Pradhan Mantri–Ayushman Bharat Health Infrastructure Mission (PM-ABHIM) allocated USD 7.4 billion to strengthen primary healthcare institutions, disease surveillance, public health labs, health research, and pandemic preparedness.

Market Challenges

Regulatory and Data-Security Requirements for Connected Spirometers to Hamper Market Growth

Data security and regulatory requirements for connected spirometers are emerging as a major restraint for the global market. Spirometers are no longer limited to standalone devices used only inside hospitals or pulmonary function laboratories. Technologically advanced devices increasingly include mobile applications, cloud dashboards, Bluetooth connectivity, EMR/EHR integration, remote patient monitoring, automated interpretation, clinical-trial portals, and home-use data transmission. While these features enhance accessibility and workflow efficiency, they also expose manufacturers and healthcare providers to stricter regulatory, cybersecurity, privacy, and software-validation requirements, further limiting the adoption rate and market growth globally.

SEGMENTATION ANALYSIS

By Product Type

Growing Funding Initiatives for Devices Led to Segmental Dominance

On the basis of product type, the market is divided into devices, software, and accessories & consumables.

The devices segment held the largest spirometer market share in 2025. The segment growth is driven by rising technological advancements in spirometer devices. Furthermore, the growing focus of key players on funding initiatives is expected to fuel R&D activities for spirometers, thereby boosting the segmental growth.

• For example, in January 2023, Aluna, a company focused on developing solutions for asthma management, received USD 15.3 million in Series B funding to scale its AI-enabled respiratory platform, including an innovative at-home spirometer and others.

The software segment is expected to grow at a CAGR of 8.4% over the forecast period.

To know how our report can help streamline your business, Speak to Analyst

By Type

Growing Prevalence of Respiratory Conditions Fueled Volume Measurement Segment Growth

On the basis of type, the market is segmented into volume measurement and peak flow meters.

The volume measurement segment held the dominant market share in 2025. The segment dominance is attributed to increasing prevalence of respiratory conditions, established use of ATS/ERS-aligned spirometry standards, and high adoption of full pulmonary function testing (PFT) systems in hospitals and specialist respiratory clinics, resulting in a growing adoption rate of these devices.

• For instance, according to 2022 data published by the Australian Institute of Health and Welfare, about 2.8 million people in Australia were estimated to be living with asthma.

The peak flow meters segment is set to flourish with a CAGR of 8.7% over the forecast period.

By Application

Growing Prevalence of Chronic Obstructive Pulmonary Disorder (COPD) Fostered Segment Growth

Based on application, the market is segmented into chronic obstructive pulmonary disorder (COPD), asthma, and others.

The chronic obstructive pulmonary disorder (COPD) segment dominated the global market with 44.7% in 2025. The increasing prevalence of COPD among the patient population is resulting in a growing adoption rate of spirometers globally, thereby contributing to the segmental growth in the market.

• For instance, according to 2024 statistics published by the Centers for Disease Control & Prevention (CDC), about 16 million adults have chronic obstructive pulmonary disease (COPD) in the U.S.

The asthma segment is set to flourish with a CAGR of 7.8% over the forecast period.

By End User

Increasing Number of Hospitals Propelled Segment Expansion

In terms of end user, the market is segmented into hospitals, diagnostic centers, homecare settings, physician/primary care offices or clinics, and other facilities.

The hospitals segment dominated the market in 2025. The growing prevalence of respiratory conditions, rising adoption of spirometer devices in hospitals, and an increasing number of hospitals are some of the major factors contributing to segment growth. Furthermore, the segment is set to hold a 39.0% share in 2026.

• For instance, according to a 2022 survey published by Radar Healthcare, it was reported that there are about 8,300 hospitals in Japan.

The diagnostic centers segment is projected to grow at an 8.0% CAGR during the forecast period.

Spirometer Market Regional Outlook

Based on region, the market has been studied across North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

North America

To get more information on the regional analysis of this market, Download Free sample

The North America market held the dominant share in 2024, valued at USD 328.3 million, and also took the leading share in 2025 with USD 358.2 million. The growing asthma burden, increasing pulmonary screening programs, rising healthcare spending, and technological advancements in spirometer products are fueling market growth.

• For instance, according to 2026 statistics published by the Centers for Medicare & Medicaid Services (CMS), healthcare spending is around USD 5.3 trillion in the U.S.

U.S. Spirometer Market

Based on North America’s strong contribution and the U.S. dominance within the region, the U.S. market can be analytically approximated at around USD 345.5 million in 2026, accounting for roughly 38.7% of global sales.

Europe

Europe is projected to record a CAGR of 7.7% in the coming years, which is the second highest among all regions, and reach a valuation of USD 205.4 million in 2026. The research and development activities among the key companies to introduce novel devices are likely to support the market growth.

U.K. Spirometer Market

The U.K. market in 2026 is estimated at around USD 36.0 million, representing roughly 4.0% of global revenues.

Germany Spirometer Market

Germany’s market is projected to reach approximately USD 37.8 million in 2026, equivalent to around 4.2% of global sales.

Asia Pacific

Asia Pacific is estimated to reach USD 217.6 million in 2026 and secure the position of the third-largest region in the market. The rapid growth driven by expanding healthcare systems and growing adoption of spirometry tests is expected to contribute to the growth of the market.

Japan Spirometer Market

The Japan market in 2026 is estimated at around USD 51.8 million, accounting for roughly 5.8% of global revenues. Japan has historically reported a relatively increasing prevalence of asthma and COPD, with a growing adoption of respiratory monitoring devices in the industry.

China Spirometer Market

China’s market is projected to be one of the largest globally, with 2026 revenues estimated at around USD 59.9 million, representing roughly 6.7% of global sales.

India Spirometer Market

The Indian market size in 2026 is estimated at around USD 23.8 million, accounting for roughly 2.7% of global revenues.

Latin America and Middle East & Africa

The Latin America and Middle East & Africa regions are expected to witness moderate growth in this market space during the forecast period. The Latin America market is set to reach a valuation of USD 44.6 million in 2026 due to the growing number of R&D activities to develop the products, which is supporting the rising demand for spirometers in the region. Market growth in the Middle East & Africa region is driven by the rising prevalence of chronic respiratory diseases and healthcare investments. In the Middle East & Africa, the GCC is set to reach a value of USD 16.4 million in 2026.

South Africa Spirometer Market

The South African market is projected to reach around USD 6.3 million in 2026, representing roughly 0.7% of global revenues.

Competitive Landscape

Key Industry Players

Major Companies Emphasize Product Certifications to Strengthen Their Market Positions

Jaeger Medical GmbH and Vitalograph are major companies in the market. A robust and diversified product portfolio, along with a significant emphasis on inorganic growth strategies globally, is one of the key factors contributing to the dominance of these companies. This, along with increasing focus on receiving certification for software, is further likely to support the global market share.

• In August 2025, Jaeger Medical GmbH, a global company in respiratory diagnostic products, received Authority to Operate (ATO) certification for its core software platform, SentrySuite, under the U.S. Department of Defense's (DoD) Risk Management Framework (RMF).

Other key players, such as ndd Medical Technologies, MGC Diagnostics Corporation, and others, have also entered the market with novel advanced spirometry devices, software, and others.

List of Key Spirometer Companies Profiled

• ndd Medizintechnik AG (Switzerland)
• COSMED srl (Italy)
• MGC Diagnostics Corporation (U.S.)
• Vitalograph (Ireland)
• Chest M.I., Inc. (Japan)
• Jaeger Medical GmbH (Germany)
• Ganshorn Medizin Electronic GmbH (Germany)
• Medical International Research S.p.A. (MIR) (Italy)
• Midmark Corporation (U.S.)

KEY INDUSTRY DEVELOPMENTS

• December 2025: COSMED srl, a global company in cardiopulmonary diagnostics, metabolic assessment solutions, and body composition technologies, acquired Ergometrix S.A., a long-established Spanish distributor specialized in electronic equipment for the healthcare and rehabilitation sectors.
• November 2025: MGC DIAGNOSTICS CORPORATION launched the Meridian Series, a next‑generation line of cardiorespiratory diagnostic systems designed to set a new standard for performance and flexibility.
• December 2024: GANSHORN Medizin Electronic GmbH received approval from the U.S. Food and Drug Administration (FDA) for the commercialization of the PowerCube+ series with an aim to strengthen its product channel.
• November 2024: ndd Medical Technologies launched EasyOne Sky, a revolutionary spirometry solution designed to tackle the global underutilization of spirometry and improve the early diagnosis and management of Chronic Obstructive Pulmonary Disease (COPD).
• July 2024: MGC DIAGNOSTICS CORPORATION launched the MIR Spirolab, an innovative, all-in-one spirometer designed for versatile use. It combines portability with comprehensive features, including a rechargeable long-life battery and 7-inch touchscreen for ease of use.
• June 2021: ERT launched ERT iSpiro Virtual Visits, which enables real-time coaching during at-home pulmonary function tests (PFT). With iSpiro Virtual Visits, ERT delivers on its commitment to offer customer- and patient-oriented innovations that enable decentralization.
• September 2020: Midmark Corp. launched the Midmark Digital Spirometer, intended to make the detection and management of asthma, COPD, and other respiratory illnesses simple and effective.

REPORT COVERAGE

The research report provides a detailed global spirometer market analysis and focuses on key aspects such as leading companies, product types, and leading product applications. Besides this, it offers insights into the market trends and highlights key industry developments. In addition to the aforementioned factors, the report encompasses several factors that have contributed to the growth of the advanced market over the recent years.

Request for Customization   to gain extensive market insights.

Report Scope & Segmentation